FindTrial
Sign In

Video based direct observed treatment via mobile phones for tuberculosis in India

Technology for TB: Mobile phone based directly observed treatment for supporting antitubercular treatment in South India - vDOT-IND

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/07/009052
Enrollment
380
Registered
2017-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Newly diagnosed tuberculosis irrespective of the site of infection Health Condition 2: A15-A19- Tuberculosis

Interventions

Intervention1: video based direct observed treatment via mobile phones: The intervention will be video based direct observed treatment along with monthly adherence counselling. For this patients will

Sponsors

St Johns Medical College under the CBCI Society for Medical Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed TB for category-I treatment irrespective of HIV status

Exclusion criteria

Exclusion criteria: (i) Multidrug resistant TB (ii) Karnofsky score of less than 70 [22]. (iii) Pregnancy (iv) Alcohol dependence

Design outcomes

Primary

MeasureTime frame
The proportion completing 6 months of antitubercular treatment in both the arms.Timepoint: Assessed 6 months after initiating antitubercular treatment.—

Secondary

MeasureTime frame
Adherence to treatment over time using urine isoniazide (INH) test strips, and or hair INH (based on validation of the test) and pill counts.Timepoint: Assessed monthly till treatment completion;Proportion of whose sputum has converted in both armsTimepoint: measured at 2 months and 6 months;Time to sputum conversion in both armsTimepoint: A cumulative measure of time, with sputum being tested at 2 months, 3 months and 6 months;Proportion resistant to antitubercular treatmentTimepoint: Assessed at the end of 6 months and 48 months in both arms;Acceptability of the intervention (participants in the intervention arm only and healthcare providers)Timepoint: 4 months and 6 months;Cost effectiveness of the interventionTimepoint: Assessed at the end of 6 months;Quality of life over timeTimepoint: Assessed at baseline, 6 months, 12 months, 18 months and 24 months;Nutritional statusTimepoint: Baseline, 6 months, 12 months, 18 months and 24 months;Physical activityTimepoint: Baseline, 6 months, 12 months, 18 months and 12 years;Validating isoniazide levels in hair samplesTimepoint: 2 months;Proportion of treatment doses viewed in the intervention vs control armsTimepoint: Based on the treatment schedule over a period of 6 months—

Countries

India

Contacts

Public ContactRashmi Rodrigues

St Johns Medical College

rashmijr@gmail.com9845389538

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026